Radionetics Oncology
Clinical trials sponsored by Radionetics Oncology, explained in plain language.
-
New Dual-Action drug targets Hard-to-Treat breast cancer
Disease control Recruiting nowThis early-stage study tests two related drugs in people with advanced hormone-receptor positive breast cancer that has spread or come back. The first drug (68Ga-R11228) helps doctors see tumors on a PET scan. The second drug (177Lu-R11228) delivers targeted radiation to kill can…
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
New PET tracer aims to light up Hard-to-Find breast cancer spots
Diagnosis Recruiting nowThis early-phase study tests a new radioactive imaging agent called 68Ga-R10602 to see if it can find tumors in people with hormone receptor-positive breast cancer that has spread or come back. About 36 adults whose cancer no longer responds to hormone therapy will receive the ag…
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Diagnosis
Last updated May 07, 2026 18:40 UTC